News

Back
February 17, 2021

Salarius Completes Dose-Escalation Stage of Phase 1/2 Clinical Trial in Relapsed and Refractory Ewing Sarcoma Patients, Initiates Expansion Stage in Ewing and Ewing-related Sarcoma Patients

Contact

Tiberend Strategic Advisors, Inc. Johanna Bennett jbennett@tiberend.com
Download PDF